Geesje M Dallinga-Thie (G M Dallinga-Thie)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Vascular Endothelial Growth Factor

Low Density Lipoprotein

Insulin Resistance

Top Venues

Expert review of cardiovascular therapy

AMC

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AMC Jun 01 2007

Netherlands

senior scientist :: vascular medicine

Publications

Marchien G Dallinga, Yasmin I Habani, Alinda W M Schimmel, Geesje M Dallinga-Thie, Cornelis J F van Noorden, Ingeborg Klaassen, Reinier O Schlingemann
The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro. Cells 10 (4) (2021)
Nick S Nurmohamed, Geesje M Dallinga-Thie, E S G Stroes
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia. Expert review of cardiovascular therapy 18 (6) (2020)
R Preethi Surendran, Shanti D Udayyapan, Mercedes Clemente-Postigo, Stefan R Havik, Alinda W M Schimmel, Fransisco Tinahones, Max Nieuwdorp, Geesje M Dallinga-Thie
Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance. PloS one 13 (11) (2018)